Engineered anti-IL-13 antibodies, compositions, methods and uses

Details for Australian Patent Application No. 2009283008 (hide)

Owner Centocor Ortho Biotech Inc.

Inventors Swanson, Ronald V.; Chi, Ellen; Raghunathan, Gopalan; Zhao, Shanrong; Fransson, Johan; Cordier, Wendy; Almagro, Juan C.; Hyun, Linus; Giles-Komar, Jill; O'Neil, Karyn T.; Carton, Jill M.; Zhou, Hong Mimi; Teplyakov, Alexey V.; Feng, Yiqing

Agent Shelston IP

Pub. Number AU-A-2009283008

PCT Pub. Number WO2010/021874

Priority 61/090,472 20.08.08 US; 61/097,232 16.09.08 US

Filing date 11 August 2009

Wipo publication date 25 February 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021874 Priority application(s): WO2010/021874

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283013-Use of ultrarapid acting insulin

2009283006-Enhancing endotoxin detection